Report Detail
Global Irritable Bowel Syndrome (IBS) Therapeutics Market Professional Survey Report 2019
- RnM3813707 |
- 14 October, 2019 |
- Global |
- 100 Pages |
- QYResearch |
- Pharma & Healthcare
IBS is a chronic disorder characterized by abdominal pain or discomfort associated with altered bowel function for at least three months, according to the Rome III criteria. Patients often experience relapse of symptoms over time.
The global Irritable Bowel Syndrome (IBS) Therapeutics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Irritable Bowel Syndrome (IBS) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Irritable Bowel Syndrome (IBS) Therapeutics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Irritable Bowel Syndrome (IBS) Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Irritable Bowel Syndrome (IBS) Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Valeant Pharmaceuticals International
Ardelyx
Astellas Pharma
Novartis
GlaxoSmithKline
Ironwood Pharmaceuticals
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Blautix (Strain)
Bekinda (IBS-D)
SYN-010
Tenapanor
Segment by Application
Hospital
Research
Table of Contents
Executive Summary
1 Industry Overview of Irritable Bowel Syndrome (IBS) Therapeutics
- 1.1 Definition of Irritable Bowel Syndrome (IBS) Therapeutics
- 1.2 Irritable Bowel Syndrome (IBS) Therapeutics Segment by Type
- 1.2.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Blautix (Strain)
- 1.2.3 Bekinda (IBS-D)
- 1.2.4 SYN-010
- 1.2.5 Tenapanor
- 1.3 Irritable Bowel Syndrome (IBS) Therapeutics Segment by Applications
- 1.3.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Research
- 1.4 Global Irritable Bowel Syndrome (IBS) Therapeutics Overall Market
- 1.4.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue (2014-2025)
- 1.4.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Production (2014-2025)
- 1.4.3 North America Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025)
- 1.4.4 Europe Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025)
- 1.4.5 China Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025)
- 1.4.6 Japan Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025)
- 1.4.8 India Irritable Bowel Syndrome (IBS) Therapeutics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Irritable Bowel Syndrome (IBS) Therapeutics
- 2.3 Manufacturing Process Analysis of Irritable Bowel Syndrome (IBS) Therapeutics
- 2.4 Industry Chain Structure of Irritable Bowel Syndrome (IBS) Therapeutics
3 Development and Manufacturing Plants Analysis of Irritable Bowel Syndrome (IBS) Therapeutics
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Irritable Bowel Syndrome (IBS) Therapeutics
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Irritable Bowel Syndrome (IBS) Therapeutics Production and Capacity Analysis
- 4.2 Irritable Bowel Syndrome (IBS) Therapeutics Revenue Analysis
- 4.3 Irritable Bowel Syndrome (IBS) Therapeutics Price Analysis
- 4.4 Market Concentration Degree
5 Irritable Bowel Syndrome (IBS) Therapeutics Regional Market Analysis
- 5.1 Irritable Bowel Syndrome (IBS) Therapeutics Production by Regions
- 5.1.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production by Regions
- 5.1.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Regions
- 5.2 Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Regions
- 5.3 North America Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis
- 5.3.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Production
- 5.3.2 North America Irritable Bowel Syndrome (IBS) Therapeutics Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Irritable Bowel Syndrome (IBS) Therapeutics Import and Export
- 5.4 Europe Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis
- 5.4.1 Europe Irritable Bowel Syndrome (IBS) Therapeutics Production
- 5.4.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Irritable Bowel Syndrome (IBS) Therapeutics Import and Export
- 5.5 China Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis
- 5.5.1 China Irritable Bowel Syndrome (IBS) Therapeutics Production
- 5.5.2 China Irritable Bowel Syndrome (IBS) Therapeutics Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Irritable Bowel Syndrome (IBS) Therapeutics Import and Export
- 5.6 Japan Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis
- 5.6.1 Japan Irritable Bowel Syndrome (IBS) Therapeutics Production
- 5.6.2 Japan Irritable Bowel Syndrome (IBS) Therapeutics Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Irritable Bowel Syndrome (IBS) Therapeutics Import and Export
- 5.7 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis
- 5.7.1 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Production
- 5.7.2 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Import and Export
- 5.8 India Irritable Bowel Syndrome (IBS) Therapeutics Market Analysis
- 5.8.1 India Irritable Bowel Syndrome (IBS) Therapeutics Production
- 5.8.2 India Irritable Bowel Syndrome (IBS) Therapeutics Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Irritable Bowel Syndrome (IBS) Therapeutics Import and Export
6 Irritable Bowel Syndrome (IBS) Therapeutics Segment Market Analysis (by Type)
- 6.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Production by Type
- 6.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Revenue by Type
- 6.3 Irritable Bowel Syndrome (IBS) Therapeutics Price by Type
7 Irritable Bowel Syndrome (IBS) Therapeutics Segment Market Analysis (by Application)
- 7.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption by Application
- 7.2 Global Irritable Bowel Syndrome (IBS) Therapeutics Consumption Market Share by Application (2014-2019)
8 Irritable Bowel Syndrome (IBS) Therapeutics Major Manufacturers Analysis
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
- 8.1.2 Abbott Laboratories Product Introduction, Application and Specification
- 8.1.3 Abbott Laboratories Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Synergy Pharmaceuticals
- 8.2.1 Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
- 8.2.2 Synergy Pharmaceuticals Product Introduction, Application and Specification
- 8.2.3 Synergy Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Sucampo Pharmaceuticals
- 8.3.1 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
- 8.3.2 Sucampo Pharmaceuticals Product Introduction, Application and Specification
- 8.3.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Valeant Pharmaceuticals International
- 8.4.1 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
- 8.4.2 Valeant Pharmaceuticals International Product Introduction, Application and Specification
- 8.4.3 Valeant Pharmaceuticals International Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Ardelyx
- 8.5.1 Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
- 8.5.2 Ardelyx Product Introduction, Application and Specification
- 8.5.3 Ardelyx Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Astellas Pharma
- 8.6.1 Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
- 8.6.2 Astellas Pharma Product Introduction, Application and Specification
- 8.6.3 Astellas Pharma Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Novartis
- 8.7.1 Novartis Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
- 8.7.2 Novartis Product Introduction, Application and Specification
- 8.7.3 Novartis Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 GlaxoSmithKline
- 8.8.1 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
- 8.8.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.8.3 GlaxoSmithKline Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Ironwood Pharmaceuticals
- 8.9.1 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production Sites and Area Served
- 8.9.2 Ironwood Pharmaceuticals Product Introduction, Application and Specification
- 8.9.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome (IBS) Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Irritable Bowel Syndrome (IBS) Therapeutics Market
- 9.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Trend Analysis
- 9.1.1 Global Irritable Bowel Syndrome (IBS) Therapeutics Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Irritable Bowel Syndrome (IBS) Therapeutics Regional Market Trend
- 9.2.1 North America Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025
- 9.2.2 Europe Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025
- 9.2.3 China Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025
- 9.2.4 Japan Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025
- 9.2.5 Southeast Asia Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025
- 9.2.6 India Irritable Bowel Syndrome (IBS) Therapeutics Forecast 2019-2025
- 9.3 Irritable Bowel Syndrome (IBS) Therapeutics Market Trend (Product Type)
- 9.4 Irritable Bowel Syndrome (IBS) Therapeutics Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Irritable Bowel Syndrome (IBS) Therapeutics Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Irritable Bowel Syndrome (IBS) Therapeutics. Industry analysis & Market Report on Irritable Bowel Syndrome (IBS) Therapeutics is a syndicated market report, published as Global Irritable Bowel Syndrome (IBS) Therapeutics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Irritable Bowel Syndrome (IBS) Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
